Stockscreener 앱 받기
10.85
2.16%
-0.24
시간 외 거래:
10.79
-0.06
-0.55%
전일 마감가:
$11.09
열려 있는:
$11.02
하루 거래량:
254.80K
Relative Volume:
0.65
시가총액:
$374.56M
수익:
$85.23M
순이익/손실:
$2.70M
주가수익비율:
172.77
EPS:
0.0628
순현금흐름:
$20.97M
1주 성능:
-4.32%
1개월 성능:
-0.09%
6개월 성능:
+27.50%
1년 성능:
-40.06%
1일 변동 폭
$10.77
$11.02
1주일 범위
$10.77
$11.72
52주 변동 폭
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.85 | 382.85M | 85.23M | 2.70M | 20.97M | 0.0628 |
ABT
Abbott Laboratories
|
88.82 | 153.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
317.75 | 120.08B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.58 | 99.27B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.81 | 83.12B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.16 | 47.44B | 6.30B | 1.07B | 1.09B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Delcath Systems announces inducement grants - Medical Buyer
How (DCTH) Movements Inform Risk Allocation Models - Stock Traders Daily
Implied volatility surging for Delcath Systems stock options - MSN
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Daily Tribune News
Delcath Systems announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
New Delcath hires receive 24,500 stock units over 3 years - Stock Titan
Dental EconomicsDelcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent
Delcath Systems, Inc.Common Stock (NQ: DCTH - FinancialContent
Delcath Systems (DCTH) director receives grant of 22,500 stock options at $11.61 - Stock Titan
Delcath Systems (NASDAQ: DCTH) director receives 22,500 stock options at $11.61 strike - Stock Titan
Delcath Systems (DCTH) director awarded 22,500 stock options at $11.61 - Stock Titan
Director at Delcath (NASDAQ: DCTH) awarded 22,500 stock options - Stock Titan
Delcath (DCTH) awards director 22,500 options at $11.61 strike - Stock Titan
Delcath Systems, Inc. 8-K Filing May 13, 2026 – Company Information, Equity Incentive Plan, and SEC Compliance 212 - Minichart
Delcath Shareholders Approve Expanded Equity Plan and Governance - TipRanks
Delcath Systems shareholders approve equity plan amendment and board elections By Investing.com - Investing.com South Africa
Delcath Systems shareholders approve equity plan amendment and board elections - Investing.com
Delcath (NASDAQ: DCTH) approves 1.8M-share boost to 2020 equity plan - Stock Titan
Earnings call transcript: Delcath Systems Q1 2026 beats EPS forecast, stock rises - Investing.com Canada
Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference - Yahoo Finance
TradingKey - TradingKey
Delcath Systems Q1 2026: -$0.03 EPS Tops Estimates — Deep Dive - AlphaStreet
Tangible book value per share of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems Balances Growth with Rising Costs - The Globe and Mail
MSN Money - MSN
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Delcath Systems, Inc. (NASDAQ:DCTH) Q1 2026 Earnings Call Transcript - Insider Monkey
Delcath Systems (NASDAQ:DCTH) Announces Quarterly Earnings Results - MarketBeat
Q1 2026 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Delcath Systems, Inc. (DCTH) Stock Analysis: Aiming for an 89.80% Upside in the Medical Device Sector - DirectorsTalk Interviews
Uveal Melanoma Treatment Market is expected to Hit US$ 2.7 - openPR.com
Delcath Systems Reports First Quarter 2026 Results and Business Highlights - BioSpace
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 - BioSpace
Number of shareholders of Delcath Systems, Inc. – DUS:DV3R - TradingView
Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN
Delcath Systems Q1 Earnings Call Highlights - MarketBeat
Delcath Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
DCTH: Q1 saw record patient starts, 36% volume growth, and strong 2026 revenue guidance - TradingView
Delcath presents data on liver cancer treatment in breast cancer patients By Investing.com - Investing.com South Africa
Delcath presents data on liver cancer treatment in breast cancer patients - Investing.com UK
Delcath Systems Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Delcath Systems (NASDAQ:DCTH) Surpasses Q1 Estimates, Guidance Points to Continued Growth - ChartMill
Delcath Systems | 10-Q: Q1 2026 Earnings Report - Moomoo
Delcath Systems (NASDAQ: DCTH) grows Q1 2026 sales but posts small loss - Stock Titan
DELCATH SYSTEMS ($DCTH) Releases Q1 2026 Earnings - Quiver Quantitative
Delcath (NASDAQ: DCTH) Q1 revenue hits $25M with 2026 outlook of $100M+ - Stock Titan
Delcath Systems Sees Positive Adjusted EBITDA for 2026 >DCTH - Moomoo
Cancer treatment company targets $100M sales with 29 centers active - Stock Titan
A liver-targeted breast cancer procedure drew new data at ESMO - Stock Titan
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
0.28%
자본화:
|
볼륨(24시간):